These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 37905957)
21. [miR-93-5p promotes invasion and migration of triple negative breast cancer cells by targeting FGD5]. Zhou D; Bai J; Hu Y; Zhang L; Zheng Q; Zhong W; Mu Q; Li H; Lyu S; Yin C Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Sep; 36(9):794-801. PubMed ID: 32967763 [TBL] [Abstract][Full Text] [Related]
22. MiR-26b-5p inhibits cell proliferation and EMT by targeting MYCBP in triple-negative breast cancer. Ma S; Wei H; Wang C; Han J; Chen X; Li Y Cell Mol Biol Lett; 2021 Dec; 26(1):52. PubMed ID: 34895159 [TBL] [Abstract][Full Text] [Related]
23. MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3. Bai X; Han G; Liu Y; Jiang H; He Q Biomed Pharmacother; 2018 Jul; 103():1482-1489. PubMed ID: 29864933 [TBL] [Abstract][Full Text] [Related]
24. MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2. Lv ZD; Yang DX; Liu XP; Jin LY; Wang XG; Yang ZC; Liu D; Zhao JJ; Kong B; Li FN; Wang HB Cell Physiol Biochem; 2017; 44(5):1785-1795. PubMed ID: 29216628 [TBL] [Abstract][Full Text] [Related]
25. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2. Chen H; Pan H; Qian Y; Zhou W; Liu X Mol Cancer; 2018 Jan; 17(1):4. PubMed ID: 29310680 [TBL] [Abstract][Full Text] [Related]
26. Racial differences in RAD51 expression are regulated by miRNA-214-5P and its inhibition synergizes with olaparib in triple-negative breast cancer. Mani C; Acharya G; Saamarthy K; Ochola D; Mereddy S; Pruitt K; Manne U; Palle K Breast Cancer Res; 2023 Apr; 25(1):44. PubMed ID: 37081516 [TBL] [Abstract][Full Text] [Related]
27. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer. Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518 [TBL] [Abstract][Full Text] [Related]
28. Circ-CSNK1G1 promotes cell proliferation, migration, invasion and glycolysis metabolism during triple-negative breast cancer progression by modulating the miR-28-5p/LDHA pathway. Zan X; Li W; Wang G; Yuan J; Ai Y; Huang J; Li Z Reprod Biol Endocrinol; 2022 Sep; 20(1):138. PubMed ID: 36109751 [TBL] [Abstract][Full Text] [Related]
29. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling. Zheng S; Li M; Miao K; Xu H J Cell Biochem; 2020 Mar; 121(3):2225-2235. PubMed ID: 31692053 [TBL] [Abstract][Full Text] [Related]
30. MYBL2-induced PITPNA-AS1 upregulates SIK2 to exert oncogenic function in triple-negative breast cancer through miR-520d-5p and DDX54. Liu B; Yao P; Xiao F; Guo J; Wu L; Yang Y J Transl Med; 2021 Aug; 19(1):333. PubMed ID: 34353336 [TBL] [Abstract][Full Text] [Related]
31. Let-7a/cMyc/CCAT1/miR-17-5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast Cancer through Modulating PD-L1. Selem NA; Nafae H; Manie T; Youness RA; Gad MZ Pathol Res Pract; 2023 Aug; 248():154579. PubMed ID: 37301086 [TBL] [Abstract][Full Text] [Related]
32. MiR-106b-5p regulates the migration and invasion of colorectal cancer cells by targeting FAT4. Pan M; Chen Q; Lu Y; Wei F; Chen C; Tang G; Huang H Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33063118 [TBL] [Abstract][Full Text] [Related]
33. MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, thereby potentiating growth-inhibitory effects of the AKT inhibitor capivasertib. Jonas K; Prinz F; Ferracin M; Krajina K; Pasculli B; Deutsch A; Madl T; Rinner B; Slaby O; Klec C; Pichler M Breast Cancer Res; 2023 Oct; 25(1):119. PubMed ID: 37803350 [TBL] [Abstract][Full Text] [Related]
34. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis. Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083 [TBL] [Abstract][Full Text] [Related]
35. miR-122-5p promotes aggression and epithelial-mesenchymal transition in triple-negative breast cancer by suppressing charged multivesicular body protein 3 through mitogen-activated protein kinase signaling. Wang Z; Wang X J Cell Physiol; 2020 Mar; 235(3):2825-2835. PubMed ID: 31541468 [TBL] [Abstract][Full Text] [Related]
36. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway. Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958 [TBL] [Abstract][Full Text] [Related]
37. Downregulation of miR-155-5p enhances the anti-tumor effect of cetuximab on triple-negative breast cancer cells via inducing cell apoptosis and pyroptosis. Xu W; Song C; Wang X; Li Y; Bai X; Liang X; Wu J; Liu J Aging (Albany NY); 2021 Jan; 13(1):228-240. PubMed ID: 33472170 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer. Ouyang M; Li Y; Ye S; Ma J; Lu L; Lv W; Chang G; Li X; Li Q; Wang S; Wang W PLoS One; 2014; 9(5):e96228. PubMed ID: 24788655 [TBL] [Abstract][Full Text] [Related]
39. PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer. Song W; Tang L; Xu Y; Xu J; Zhang W; Xie H; Wang S; Guan X Sci Rep; 2017 Feb; 7():42319. PubMed ID: 28176879 [TBL] [Abstract][Full Text] [Related]
40. Up-regulation of oxidized low-density lipoprotein receptor 1 correlates with decreased miR-106b-5p, miR-93-5p, miR-3129-5p, miR-199b-3p, and miR-4465, higher recurrence rate, and poor prognosis in ovarian cancer. Liu J; Zeng Y; Zheng L Histol Histopathol; 2023 Apr; 38(4):475-485. PubMed ID: 36264049 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]